D-2570 study for people with and without liver issues
Treatments studied
This trial tests how a drug called D-2570 is processed in people with different levels of liver function. It compares people with liver impairment to those with healthy livers to see how the drug moves through the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- If you have normal liver function, your blood counts and kidney and liver tests must be adequate.
- Men must weigh at least 50 kg (about 110 pounds) and women at least 45 kg (about 99 pounds).
- You agree not to donate sperm or eggs, and to use effective birth control or avoid sex from screening until 30 days after the last dose.
- You are not pregnant or breastfeeding, and you do not have a history of drug abuse.
- You have not taken another experimental drug in the past 3 months, and you have not had surgery that would affect drug absorption.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a new drug, D-2570, is processed by the body in people with normal or reduced kidney function. It aims to understand if kidney function affects how the drug works, which could help guide dosing.
This study checks how a new medicine, D-2570, interacts with other drugs in healthy adults. It helps find the right dose and safety before it is tested in patients.
This study tests a new medicine for people with mild or moderate liver problems to see how the liver affects the drug in the body. It also includes people with normal liver function for comparison.
This trial tests a new oral medication called D-2570 for people with active systemic lupus erythematosus (SLE). It aims to see if the drug can help control lupus symptoms while you continue your current stable treatments.
This study looks at how the medicine PF-07328948 is processed by people with different levels of liver function. It includes both healthy people and those with stable liver disease (classified as mild, moderate, or severe). The goal is to see if the liver condition affects how the drug works in the body.
This trial tests an experimental drug, D-2570, for people with moderate to severe plaque psoriasis. It aims to see if the medication can safely improve skin symptoms.
Hear when a new Healthy Adult Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.